Pancytopenia: Adverse Event or Study Discontinuation

Reported in 6.7% (10/149) of patients;
- Not reported in patients with Rai Stage 0-II
- All 10 were Rai Stage III or IV CLL

All 8 patients with more than 3 weeks follow-up recovered and experienced improvement over baseline platelet count

Integrated Safety Database (N=149)

Reported in 6.7% (10/149) of patients;